To reduce serious influenza-related illness and death, the Centers for Disease Control and Prevention now recommends that all persons aged 50 and older receive an annual flu shot. Previously, the recommendation had included annual vaccination for all persons aged 65 and older, but the CDC found that up to a third of those 50 to 64 have chronic medical conditions that put them at increased risk for flu-related complications and death.
To reduce serious influenza-related illness and death, the Centers for Disease Control and Prevention now recommends that all persons aged 50 and older receive an annual flu shot. Previously, the recommendation had included annual vaccination for all persons aged 65 and older, but the CDC found that up to a third of those 50 to 64 have chronic medical conditions that put them at increased risk for flu-related complications and death.
In addition to all persons aged 50 and older, the CDC recommends influenza vaccination of the following high-risk groups for the 2000-2001 flu season:
• Residents of nursing homes and other chronic-care facilities that house persons of any age who have chronic medical conditions.
• Adults and children who have chronic disorders of the pulmonary or cardiovascular systems, including asthma.
• Adults and children who have regular medical follow-up or hospitalization during the preceding year because of shrink metabolic diseases (including diabetes mellitus), renal dysfunction, hemoglobinopathies or immunosuppression (including immunosuppression caused by medications or by human immunodeficiency virus).
• Children and teenagers (aged six months to 18 years) who are receiving long-term aspirin therapy and therefore might be at risk for developing Reye syndrome after influenza infection.
• Women who will be in the second or third trimester of pregnancy during the influenza season.
According to the CDC, influenza causes an average of 20,000 deaths and 110,000 hospitalizations in the United States per year. PR
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.